{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:41:04Z","timestamp":1787006464027,"version":"build-2736575974"},"reference-count":62,"publisher":"Informa UK Limited","issue":"1","funder":[{"DOI":"10.13039\/501100021771","name":"Student Research Committee, Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["75934"],"award-info":[{"award-number":["75934"]}],"id":[{"id":"10.13039\/501100021771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Development and Industrial Pharmacy"],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.1080\/03639045.2025.2586762","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T07:08:07Z","timestamp":1762758487000},"page":"138-152","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Design expert analysis of tacrolimus compatibility with common excipients"],"prefix":"10.1080","volume":"52","author":[{"given":"Sara","family":"Sajjadi","sequence":"first","affiliation":[{"name":"Student Research Committee, Tabriz University of Medical Sciences","place":["Tabriz, Iran"]},{"name":"Pharmaceutical and Food Control Department, Faculty of Pharmacy, Tabriz University of Medical Sciences","place":["Tabriz, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shayanfar","sequence":"additional","affiliation":[{"name":"Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences","place":["Tabriz, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Siahi-Shadbad","sequence":"additional","affiliation":[{"name":"Pharmaceutical and Food Control Department, Faculty of Pharmacy, Tabriz University of Medical Sciences","place":["Tabriz, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.40.1249"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.34172\/ia.2022.13"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2024.100285"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2480"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.22336\/rjo.2024.19"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.4103\/cdr.cdr_121_23"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.05.074"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.4103\/PAJO.PAJO_45_20"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31823f8c9b"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/02713680802149115"},{"key":"e_1_3_6_12_1","first-page":"633","volume-title":"Pharmaceutical excipients","author":"Shah H","year":"2021","unstructured":"Shah H, Jain A, Laghate G, et al. Pharmaceutical excipients. Remington: elsevier; 2021. p. 633\u2013643."},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.61173\/04tryy04"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1051\/bioconf\/20236101029"},{"issue":"5","key":"e_1_3_6_15_1","first-page":"14","article-title":"Drug-Excipient compatibility studies: first step for dosage form development","volume":"4","author":"Patel P","year":"2015","unstructured":"Patel P, Ahir K, Patel V, et al. Drug-Excipient compatibility studies: first step for dosage form development. Pharma Innov. 2015;4(5)Part A)::14.","journal-title":"Pharma Innov"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.3126\/jucms.v12i02.69619"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/10837450600561281"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.3109\/10837450.2013.778869"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2005.12.017"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600720333"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600700641"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.2174\/1872211314666210604120619"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.matdes.2024.113124"},{"issue":"1","key":"e_1_3_6_24_1","first-page":"e20240","article-title":"Optimization of HPMC-Based oral fast dissolving film of cetirizine dihydrochloride","volume":"23","author":"Saepang K","year":"2024","unstructured":"Saepang K, Pitaksuteepong T, Buranrat B, et al. Optimization of HPMC-Based oral fast dissolving film of cetirizine dihydrochloride. Nat Life Sci Commun. 2024;23(1):e20240.","journal-title":"Nat Life Sci Commun"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/polym14163406"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2023.11.004"},{"issue":"148","key":"e_1_3_6_27_1","first-page":"337","article-title":"Formulation and sustained-release of verapamil hydrochloride tablets","volume":"76","author":"Mahmoud ZH","year":"2023","unstructured":"Mahmoud ZH, Mahdi AB, Alnassar YS, et al. Formulation and sustained-release of verapamil hydrochloride tablets. Chem. 2023;76(148):337\u2013346.","journal-title":"Chem"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02980-x"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-811720-0.00005-2"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2015.02.047"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2017.1291672"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902018000001006"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.indcrop.2014.05.042"},{"key":"e_1_3_6_34_1","first-page":"1","volume-title":"Tacrolimus Capsules. United States Pharmacopeia and National Formulary (USP 46\u2013NF 41)","author":"Convention USP","year":"2024","unstructured":"Convention USP. Tacrolimus Capsules. United States Pharmacopeia and National Formulary (USP 46\u2013NF 41). 56th ed: United States Pharmacopeial Convention; 2024. Rockville, MD. p. 1\u20137.","edition":"56"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(82)90049-7"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104863"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.10.028"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1211\/jpp\/60.12.0003"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2011.643896"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.14227\/DT150208P18"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102015"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-013-0036-0"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2010.11.043"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1021\/ie2010725"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121470"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/10837450.2020.1839763"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0043-1648(77)90069-2"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsusc.2008.08.009"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11094-010-0405-x"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10973-021-10741-2"},{"issue":"2","key":"e_1_3_6_51_1","first-page":"240","article-title":"Magnesium stearate is an incompatible excipient for aspirin in wet granulation producing non-linear degradation","volume":"10","author":"D\u2019cruz D","year":"2018","unstructured":"D\u2019cruz D, Ajith A, Subburaj T, et al. Magnesium stearate is an incompatible excipient for aspirin in wet granulation producing non-linear degradation. J Pharm Sci Res. 2018;10(2):240\u2013242.","journal-title":"J Pharm Sci Res"},{"issue":"2","key":"e_1_3_6_52_1","first-page":"191","article-title":"Compatibility study of ibuprofen with some excipients employed for solid dosage forms","volume":"66","author":"Dragan F","year":"2015","unstructured":"Dragan F, Kacso I, Dreve S, et al. Compatibility study of ibuprofen with some excipients employed for solid dosage forms. Rev Chim. 2015;66(2):191\u2013195.","journal-title":"Rev Chim"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.4028\/www.scientific.net\/KEM.856.190"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2012.657644"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11094-009-0304-1"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10973-005-0047-5"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.powtec.2015.09.007"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2009.06.012"},{"issue":"3","key":"e_1_3_6_59_1","first-page":"183","article-title":"Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods","volume":"64","author":"Thumma S","year":"2009","unstructured":"Thumma S, Repka M. Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods. Pharmazie. 2009;64(3):183\u2013189.","journal-title":"Pharmazie"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2005.06.016"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1021\/js9702067"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101362"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10973-014-4316-z"}],"container-title":["Drug Development and Industrial Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03639045.2025.2586762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:45:55Z","timestamp":1767689155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03639045.2025.2586762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"alternative-id":["10.1080\/03639045.2025.2586762"],"URL":"https:\/\/doi.org\/10.1080\/03639045.2025.2586762","relation":{},"ISSN":["0363-9045","1520-5762"],"issn-type":[{"value":"0363-9045","type":"print"},{"value":"1520-5762","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iddi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iddi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}